Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome.
about
Interindividual variability in the cardiac expression of anthracycline reductases in donors with and without Down syndrome.MicroRNAs differentially regulate carbonyl reductase 1 (CBR1) gene expression dependent on the allele status of the common polymorphic variant rs9024.Chromosome 21-derived hsa-miR-155-5p regulates mitochondrial biogenesis by targeting Mitochondrial Transcription Factor A (TFAM).Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome.Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.Role of DNA Methylation on the Expression of the Anthracycline Metabolizing Enzyme AKR7A2 in Human Heart.Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.Development of a CART Model to Predict the Synthesis of Cardiotoxic Daunorubicinol in Heart Tissue Samples From Donors With and Without Down Syndrome.Functional characterization of drug uptake and metabolism in the heart.The role of carbonyl reductase 1 in drug discovery and development.Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial.Pharmacotherapeutic Considerations for Individuals with Down Syndrome.Induction of carbonyl reductase 1 (CBR1) expression in human lung tissues and lung cancer cells by the cigarette smoke constituent benzo[a]pyrene
P2860
Q33784640-77F908BE-FA47-49C7-8E35-7E9102458D10Q34469794-984D3305-5D9E-456A-BA39-2DFB38B11E8CQ34669291-2F7F2F73-1292-4C1F-A670-0616577EB846Q35044480-5C06A7DE-A8EE-4F3F-B1A8-AAD7150C2C06Q36058273-734A6DDB-ED50-412E-9F85-2649691B6FCBQ36276059-4E4826DF-D0C5-49E3-AE56-DCC56F4834DEQ36828315-FB639A7F-1E83-4952-8358-AF644B54CD32Q36948463-033F6A01-466F-4926-9909-BBD21E76FDCEQ37922773-2ACBD415-B2CE-48AF-AFBC-B6CAB261B317Q38656979-0A1A51BB-D0E4-4A39-A8EA-22A1564B8CDAQ38733360-BD804E36-BF8F-428B-BA68-3FB29F269D34Q39032991-DA798931-679A-46D0-8D5D-B1FF64B4761FQ39359263-EC2CC157-B7E9-47B2-89CC-6CA850359713
P2860
Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expression of the anthracyclin ...... rom donors with Down syndrome.
@ast
Expression of the anthracyclin ...... rom donors with Down syndrome.
@en
Expression of the anthracyclin ...... rom donors with Down syndrome.
@nl
type
label
Expression of the anthracyclin ...... rom donors with Down syndrome.
@ast
Expression of the anthracyclin ...... rom donors with Down syndrome.
@en
Expression of the anthracyclin ...... rom donors with Down syndrome.
@nl
prefLabel
Expression of the anthracyclin ...... rom donors with Down syndrome.
@ast
Expression of the anthracyclin ...... rom donors with Down syndrome.
@en
Expression of the anthracyclin ...... rom donors with Down syndrome.
@nl
P2093
P2860
P356
P1476
Expression of the anthracyclin ...... rom donors with Down syndrome.
@en
P2093
Carrie C Sanborn
James L Kalabus
Javier G Blanco
Qiuying Cheng
Raqeeb G Jamil
P2860
P304
P356
10.1124/DMD.110.035550
P577
2010-08-20T00:00:00Z